Pharma & Biotech Patent Litigation Europe - Agenda | Kisaco Research
Agenda Days: 
  • Day Zero (UPC Litigation Forum): Monday, 19 Jan, 2026
    09:00am - 10:00am
    Registration
    10:00am - 10:10am
    Chair’s Introduction to the UPC Litigation Forum
    10:10am - 11:00am

    Claim Construction at the UPC: A Review of EPO, National and UPC Case Law

    Claim Construction at the UPC: A Review of EPO, National and UPC Case Law This session examines the UPC’s evolving approach to claim interpretation, highlighting key decisions that clarify how claims are construed in comparison with EPO and national practices. It will explore recent landmark rulings and ongoing developments shaping patent litigation strategies.


    • Review the UPC Court of Appeal decision NanoString Technologies v. 10xGenomics, which clarified the standard for interpreting patent claims based on Article 69 EPC and its Protocol, affecting both infringement and validity assessments.
    • Examine the ongoing question of whether the file wrapper should be considered in claim construction, which awaits a final decision by the UPC Court of Appeal.
    • Analyse the decision of G1/24 and its impact upon claims raised at national courts, the EPO and the UPC.

    Speaker(s): 
    Session Type: 
    Panel
    11:00am - 11:45am

    The Development of the Doctrine of Equivalents Case Law: Comparing the UPC with National Jurisdictions

    This session examines how the UPC’s evolving case law on equivalence compares with national practices in jurisdictions such as the UK, Germany, and Brazil. With recent UPC decisions applying the four-prong test to life sciences disputes, panellists will assess whether the doctrine is delivering legal certainty while ensuring fair protection for patentees.

    • Analyse how recent UPC rulings apply the doctrine of equivalents and compare with approaches in the UK, Germany, and Brazil.
    • Are the four key UPC questions workable in practice, especially in the life sciences context?
    • Evaluate the balance between legal certainty for third parties and fair protection for patent holders under the UPC system.

    Speaker(s): 

    Author:

    Viviane Kunisawa

    Partner
    Daniel Law

    Viviane Kunisawa

    Partner
    Daniel Law
    Session Type: 
    Panel
    11:45am - 12:15pm
    Networking Break
    12:15pm - 13:15pm

    UPC Judges Panel Session: Understanding the Case Law and Operations Behind the Decision Makers at the Court

    Join an exclusive panel featuring esteemed judges from the UPC, whose decisions are shaping the future of patent litigation across Europe. This prestigious session offers a rar opportunity to gain invaluable insights into the judicial mindset and decision-making processes at one of the most important new patent courts globally. Don’t miss this chance to engage with the very authorities defining the UPC’s jurisprudence and influencing litigation strategies across industries.

    Speaker(s): 

    Author:

    Emmanuel Gougé

    Honourable Judge
    UPC Court of Appeal

    Emmanuel Gougé

    Honourable Judge
    UPC Court of Appeal

    Author:

    Kai Harmand

    Honourable Judge
    UPC Court of First Instance

    Kai Harmand

    Honourable Judge
    UPC Court of First Instance

    Author:

    Peter Blok

    Honourable Judge
    UPC Court of Appeal

    Peter Blok

    Honourable Judge
    UPC Court of Appeal
    Session Type: 
    General Session (Presentation)
    13:15pm - 14:15pm
    Networking Lunch
    14:15pm - 15:00pm

    The UPC and Injunctions: Is the Court Shaping up to be Pro-Patentee?

    With the UPC issuing an increasing number of rulings, its developing case law on injunctions is critical for shaping enforcement strategies. For IP counsel and litigators, understanding how and when the UPC is willing to grant or deny injunctions - whether preliminary or permanent - is essential for advising clients, managing litigation risk, and crafting effective pan-European strategies.


    • Review Grundfos v. Canned Motor Pump (Düsseldorf LD), where the court issued a permanent injunction despite ongoing licensing talks and clarified that lack of inventive step must be explicitly argued - not merely referenced via prior art.
    • Analyse Boehringer v. Zentiva (Lisbon LD), in which the court denied provisional measures due to lack of proof of imminent infringement, offering key insights into evidentiary thresholds at the UPC.
    • Understand the Milan LD’s approach to litigation costs in Ericsson v. Digital River and Oerlikon v. Bhagat, highlighting how procedural context and case complexity affect fee shifting.
    • Discuss how this growing body of UPC injunction case law is influencing strategic decision-making across industries and jurisdictions.

    Session Type: 
    General Session (Presentation)
    15:00pm - 15:45pm

    UPC Case Law Review: A Discussion of the Trends and Changes Taking Place at Europe’s Newest Patent Court

    As the UPC continues to take shape through early rulings, procedural clarifications, and appeals, legal teams across Europe are watching closely to understand how this new venue is redefining enforcement strategy. This session offers a practical review of the key decisions to date, considers procedural and jurisdictional trends, and examines the strategic calculus of litigating in the UPC versus national courts.


    • Review recent UPC case law and appeals to understand emerging judicial approaches and procedural norms:
    - Edwards Lifesciences v Meril (2025)
    - Mul-T-Lock v IMC Créations (2025)
    - Abbott Diabetes Care v Sibio Technology (2025)
    • Examine strategic decision-making: when and why companies are choosing the UPC over national courts. Compare early UPC developments to UK patent litigation to identify points of convergence and divergence.

    Session Type: 
    Panel
    15:45pm - 16:00pm
    Networking Break
    16:00pm - 16:45pm
    Interactive Workshop Session
    16:45pm -
Event Reference: 
The Pharma & Biotech Patent Litigation Summit, Europe